Setup News Ticker
Searching for 'Stock Buy'. (Return)

The Motley FoolSep 19, 2020
3 Best Dividend Stocks to Buy During a Stock Market Crash
Durability is the best word to describe these dividend stocks.

3 Tech Stocks to Buy in the Market Correction (The Motley Fool)
2 Industrial Stocks You Can Buy and Hold for the Next Decade (The Motley Fool)

The Motley FoolSep 19, 2020
Here's Why You Should Buy Macao Casino Stocks Before October
Odds are good this is where the resorts start their recovery.

Should You Buy ONEOK Stock for Its 13% Dividend Yield? (The Motley Fool)
2 Hated Dividend Stocks to Buy Now (The Motley Fool)

Forbes HeadlinesSep 19, 2020
PS5 Pre-Orders: Walmart Will Have More Stock Soon, But There's A Catch
Walmart is getting new stock for PS5 pre-orders, so you'll get another chance to buy one soon. There's a catch, however.

Yahoo BusinessSep 18, 2020
Is Pfizer Stock a Buy Right Now? This Is What You Need to Know
"Big Pharma" doesn't come much bigger than Pfizer (PFE). Although you could argue it is so big, the stock can hardly move. Shares are essentially trading for the same price as 3 years ago. Pfizer is also one of the leading names in the hunt for a COVID-19 vaccine. But unlike other names in the race to be first to market with a solution, the catalyst has had no bearing on the stock.However, after attending the company's investor presentation, Mizuho analyst Vamil Divan believes the event "successfully illustrated how the company is evolving into a ‘New Pfizer.'"Pfizer has an extensive pipeline of vaccines and treatments that it expects will generate over $15 billion of annual sales by 2025. The "New Pfizer" is also an attempt to highlight the giant's growth potential. The upcoming spin-off of its Upjohn portfolio should rid it of unwanted bulk and help it become an "innovation-driven biopharma company." The company expects to grow the top-line by 6% a year, while delivering double-digit growth on the bottom line.On the rare diseases front, Pfizer anticipates six rare disease assets will be in Phase 3 trials by the end of the year, including three gene therapies.The company is also developing a wide range of immunology products, "each for a targeted number of indications where there appears the potential for a truly differentiated product."Leading the charge form this business unit is abrocitinib, an oral JAK-inhibitor which Pfizer last month filed for the treatment of atopic dermatitis. Pfizer believes the treatmen

KiplingerSep 18, 2020
Stock Market Today: Wild Friday Features More Woes for Tech
Friday was expected to be an active day for stocks, and, on that front, it didn't disappoint.

Today was a "quadruple witching" day, in which index futures, index options, stock options and individual-stock futures all expire at once, which sometimes leads to heavy volume and erratic moves in parts or all of the market. In this case, the major indices flipped from early gains to deep losses, then recovered somewhat before closing in the red. The Dow Jones Industrial Average finished 0.9% lower to 27,657.

SEE MORE 20 Best Stocks to Buy for the New Bull Market Friday continued a brutal stretch for tech. The S&P 500's technology sector, as measured by the Technology Select Sector SPDR Fund (XLK, -1.7%), has declined 9.5% since the start of September. Apple (AAPL, -3.2%) has declined 17% this month, (AMZN, -1.8%) is off 14.4% and Microsoft (MSFT, -1.2%) is off 9.8%.

Other action in the stock market today:

The Nasdaq Composite dropped 1.1% to 10,793, putting it down 8.3% for September.The S&P 500 also fell 1.1% to 3,319. The Russell 2000 was the strongest of the major indices, slipping 0.4% to 1,536. Too Rocky for Your Tastes? Build a More Diversified

TrumpTikTok Will WeChat Ginsburg Court
Coronavirusvaccine CDC Americans Trump Europe
Stockmarket Tech Buy These Week
TikTokWeChat Trump Ban Sunday bans
Covid-19vaccine Coronavirus amid | Their
GinsburgRuth Bader Justice Supreme Court
StocksTech Market Week These Buy
WeChatTikTok Trump ban Sunday bans
MarketStock Stocks Tech Friday About
ChinaTikTok WeChat currency best week

Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money Real Estate News Analysis Indicators
Enterprise Application News
Forbes Headlines
Forbes Social Media News - China, Economy & Trade - Financial Markets - Hedge Funds - Telecoms - US
Google Business News
Google Market News
HBS Working Knowledge
INSEAD Knowledge
International Tax Review
L.S. Starrett News
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money Updates: News Digest
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC